{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:17:16Z","timestamp":1793845036125,"version":"4.6.1"},"reference-count":140,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019189","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019189","id-type":"DOI","asserted-by":"publisher"}]},{"name":"InCarda Therapeutics"},{"DOI":"10.13039\/100018890","name":"Dutch Cardiovascular Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["848090001"],"award-info":[{"award-number":["848090001"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["2018B017"],"award-info":[{"award-number":["2018B017"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Netherlands Cardiovascular Research Initiative"},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["847770"],"award-info":[{"award-number":["847770"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008732","name":"EVER Neuro Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer-Ingelheim"},{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Acesion Pharma","id":[{"id":"https:\/\/ror.org\/05b3amq72","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Adagio Medical"},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016304","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CathRx","id":[{"id":"https:\/\/ror.org\/01jc4ps18","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Pacemate"},{"name":"Boston Scientific, Medtronic, Abbott, and Becton Dickenson","id":[{"id":"https:\/\/ror.org\/03kjsjz16","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Astra Zeneca"},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007723","name":"Oxford University Press","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PassPACES"},{"DOI":"10.13039\/501100000395","name":"Royal College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007330","name":"AtriCure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020150","name":"BioVentrix","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014384","name":"Amarin Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014384","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer Innovative Target Exploration Network"},{"name":"HealthLumen"},{"name":"Fitfile"},{"DOI":"10.13039\/501100023453","name":"Norgine BV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Danish Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vifor International"},{"DOI":"10.13039\/501100014337","name":"Menarini Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014091","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014091","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vifor International"},{"name":"Vifor International"},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Centre for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z1710103"],"award-info":[{"award-number":["81Z1710103"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Centre for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z1710103"],"award-info":[{"award-number":["81Z1710103"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Centre for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z0710114"],"award-info":[{"award-number":["81Z0710114"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Centre for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z1710103"],"award-info":[{"award-number":["81Z1710103"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Centre for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z0710114"],"award-info":[{"award-number":["81Z0710114"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERACoSysMed3","award":["031L0239"],"award-info":[{"award-number":["031L0239"]}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["101095480"],"award-info":[{"award-number":["101095480"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"EU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004937","name":"German Ministry for Research and Technology","doi-asserted-by":"publisher","award":["BMBF 01ZX1408A"],"award-info":[{"award-number":["BMBF 01ZX1408A"]}],"id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004937","name":"German Ministry for Research and Technology","doi-asserted-by":"publisher","award":["BMBF 01ZX1408A"],"award-info":[{"award-number":["BMBF 01ZX1408A"]}],"id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004937","name":"German Ministry for Research and Technology","doi-asserted-by":"publisher","award":["BMBF 01ZX1408A"],"award-info":[{"award-number":["BMBF 01ZX1408A"]}],"id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sun Wave Pharma"},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR CDF-2015-08-074 RATE-AF"],"award-info":[{"award-number":["NIHR CDF-2015-08-074 RATE-AF"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR130280 DaRe2THINK"],"award-info":[{"award-number":["NIHR130280 DaRe2THINK"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR132974 D2T-NeuroVascular"],"award-info":[{"award-number":["NIHR132974 D2T-NeuroVascular"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR203326"],"award-info":[{"award-number":["NIHR203326"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/CDRF\/21\/21032"],"award-info":[{"award-number":["FS\/CDRF\/21\/21032"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/55\/33087"],"award-info":[{"award-number":["PG\/17\/55\/33087"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/2\/34218"],"award-info":[{"award-number":["AA\/18\/2\/34218"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/CDRF\/21\/21032"],"award-info":[{"award-number":["FS\/CDRF\/21\/21032"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU Horizon"},{"name":"R&D Subnational Secure Data Environment Programme"},{"DOI":"10.13039\/100003263","name":"Pioneer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003263","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cook and Wolstenholme Charitable Trust"},{"DOI":"10.13039\/501100000860","name":"European Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018942","name":"Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atrial fibrillation (AF) remains the most common cardiac arrhythmia worldwide and is associated with significant morbidity and mortality. The European Society of Cardiology (ESC)\/European Association for Cardio-Thoracic Surgery (EACTS) have recently released the 2024 guidelines for the management of AF. This review highlights 10 novel aspects of the ESC\/EACTS 2024 Guidelines. The AF-CARE framework is introduced, a structural approach that aims to improve patient care and outcomes, comprising of four pillars: [C] Comorbidity and risk factor management, [A] Avoid stroke and thromboembolism, [R] Reduce symptoms by rate and rhythm control, and [E] Evaluation and dynamic reassessment. Additionally, graphical patient pathways are provided to enhance clinical application. A significant shift is the new emphasis on comorbidity and risk factor control to reduce AF recurrence and progression. Individualized assessment of risk is suggested to guide the initiation of oral anticoagulation to prevent thromboembolism. New guidance is provided for anticoagulation in patients with trigger-induced and device-detected sub-clinical AF, ischaemic stroke despite anticoagulation, and the indications for percutaneous\/surgical left atrial appendage exclusion. AF ablation is a first-line rhythm control option for suitable patients with paroxysmal AF, and in specific patients, rhythm control can improve prognosis. The AF duration threshold for early cardioversion was reduced from 48 to 24\u2005h, and a wait-and-see approach for spontaneous conversion is advised to promote patient safety. Lastly, strong emphasis is given to optimize the implementation of AF guidelines in daily practice using a patient-centred, multidisciplinary and shared-care approach, with the simultaneous launch of a patient version of the guideline.<\/jats:p>","DOI":"10.1093\/europace\/euae298","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T15:27:06Z","timestamp":1734708426000},"source":"Crossref","is-referenced-by-count":144,"title":["Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-070X","authenticated-orcid":false,"given":"Michiel","family":"Rienstra","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen , P.O. Box 30.001, 9700 RB Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-1928","authenticated-orcid":false,"given":"Stylianos","family":"Tzeis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mitera Hospital , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-4377","authenticated-orcid":false,"given":"Karina V","family":"Bunting","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-8891","authenticated-orcid":false,"given":"Valeria","family":"Caso","sequence":"additional","affiliation":[{"name":"Stroke Unit, Santa Maria della Misericordia-University of Perugia , Perugia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-5337","authenticated-orcid":false,"given":"Harry J G M","family":"Crijns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Center , Maastricht ,","place":["The Netherlands"]},{"name":"Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1424-114X","authenticated-orcid":false,"given":"Tom J R","family":"De Potter","sequence":"additional","affiliation":[{"name":"Department of Cardiology, OLV Hospital , Aalst ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3803-8429","authenticated-orcid":false,"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[{"name":"Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital , Adelaide, SA ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-0870","authenticated-orcid":false,"given":"Emma","family":"Svennberg","sequence":"additional","affiliation":[{"name":"Department of Medicine Karolinska University Hospital (MedH), Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3876-6074","authenticated-orcid":false,"given":"Ruben","family":"Casado-Arroyo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, H.U.B.-H\u00f4pital Erasme, Universit\u00e9 Libre de Bruxelles , Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Dwight","sequence":"additional","affiliation":[{"name":"ESC Patient Forum, Sophia Antipolis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-4864","authenticated-orcid":false,"given":"Luigina","family":"Guasti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Insubria , Varese ,","place":["Italy"]},{"name":"Division of Geriatrics and Clinical Gerontology, ASST-Settelaghi , Varese ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8481-4700","authenticated-orcid":false,"given":"Thorsten","family":"Hanke","sequence":"additional","affiliation":[{"name":"Clinic For Cardiac Surgery, Asklepios Klinikum, Harburg , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4197-4026","authenticated-orcid":false,"given":"Tiny","family":"Jaarsma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Linkoping University , Linkoping ,","place":["Sweden"]},{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0146-9196","authenticated-orcid":false,"given":"Maddalena","family":"Lettino","sequence":"additional","affiliation":[{"name":"Department for Cardiac, Thoracic and Vascular Diseases, Fondazione IRCCS San Gerardo dei Tintori , Monza ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8532-6573","authenticated-orcid":false,"given":"Maja-Lisa","family":"L\u00f8chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, UiT, The Arctic University of Norway , Troms\u00f8 ,","place":["Norway"]},{"name":"Department of Cardiology, University Hospital of North Norway , Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-4741","authenticated-orcid":false,"given":"R Thomas","family":"Lumbers","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London , London ,","place":["UK"]},{"name":"Saint Bartholomew\u2019s Hospital, Barts Health NHS Trust , London ,","place":["UK"]},{"name":"University College Hospital, University College London Hospitals NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-1450","authenticated-orcid":false,"given":"Bart","family":"Maesen","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Maastricht University Medical Centre+ , Maastricht ,","place":["The Netherlands"]},{"name":"Cardiovascular Research Institute Maastricht, Maastricht University , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"M\u00f8lgaard","sequence":"additional","affiliation":[{"name":"ESC Patient Forum, Sophia Antipolis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4023-2263","authenticated-orcid":false,"given":"Giuseppe M C","family":"Rosano","sequence":"additional","affiliation":[{"name":"Department of Human Sciences and Promotion of Quality of Life, Chair of Pharmacology, San Raffaele University of Rome , Rome ,","place":["Italy"]},{"name":"Department of Cardiology, San Raffaele Cassino Hospital , Cassino ,","place":["Italy"]},{"name":"Cardiovascular Academic Group, St George\u2019s University Medical School , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-9509","authenticated-orcid":false,"given":"Renate B","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Cardiology University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK) Partner Site Hamburg\/Kiel\/L\u00fcbeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2670-4164","authenticated-orcid":false,"given":"Piotr","family":"Suwalski","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-7758","authenticated-orcid":false,"given":"Juan","family":"Tamargo","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology School of Medicine, Universidad Complutense , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-122X","authenticated-orcid":false,"given":"Otilia","family":"Tica","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Birmingham ,","place":["UK"]},{"name":"Department of Cardiology, Emergency County Clinical Hospital of Bihor , Oradea ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-6416","authenticated-orcid":false,"given":"Vassil","family":"Traykov","sequence":"additional","affiliation":[{"name":"Department of Invasive Electrophysiology, Acibadem City Clinic Tokuda University Hospital , Sofia ,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-9812","authenticated-orcid":false,"given":"Dipak","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Birmingham ,","place":["UK"]},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7579-1201","authenticated-orcid":false,"given":"Isabelle C","family":"Van Gelder","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen , P.O. Box 30.001, 9700 RB Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"2024122405404917200_euae298-B1","doi-asserted-by":"crossref","first-page":"euae195","DOI":"10.1093\/europace\/euae195","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2021","volume":"26","author":"Cheng","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B2","doi-asserted-by":"crossref","first-page":"euae146","DOI":"10.1093\/europace\/euae146","article-title":"Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry","volume":"26","author":"Walli-Attaei","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B3","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1038\/s41591-024-03049-9","article-title":"Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk","volume":"30","author":"Mobley","year":"2024","journal-title":"Nat Med"},{"key":"2024122405404917200_euae298-B4","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B5","doi-asserted-by":"crossref","first-page":"euae078","DOI":"10.1093\/europace\/euae078","article-title":"A call for action to include psychosocial management into holistic, integrated care for patients with atrial fibrillation","volume":"26","author":"Brandes","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B7","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B8","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B9","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"2024122405404917200_euae298-B10","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B11","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B12","doi-asserted-by":"crossref","first-page":"e1003599","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"2024122405404917200_euae298-B13","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCULATIONAHA.116.026230","article-title":"Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [Substrate Modification with Aggressive Blood Pressure Control])","volume":"135","author":"Parkash","year":"2017","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B15","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B16","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"2024122405404917200_euae298-B17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B19","doi-asserted-by":"crossref","first-page":"e022222","DOI":"10.1161\/JAHA.121.022222","article-title":"Sodium-glucose co-transporter inhibitors and atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Pandey","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2024122405404917200_euae298-B20","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jchf.2021.11.006","article-title":"Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: DELIVER trial","volume":"10","author":"Solomon","year":"2022","journal-title":"JACC Heart Fail"},{"key":"2024122405404917200_euae298-B22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2006.03.034","article-title":"Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation","volume":"116","author":"Hegbom","year":"2007","journal-title":"Int J Cardiol"},{"key":"2024122405404917200_euae298-B26","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ahj.2011.09.013","article-title":"A randomized study of the effects of exercise training on patients with atrial fibrillation","volume":"162","author":"Osbak","year":"2011","journal-title":"Am Heart J"},{"key":"2024122405404917200_euae298-B27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.115.018220","article-title":"Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial","volume":"133","author":"Malmo","year":"2016","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/HCR.0000000000000665","article-title":"Effects of supervised exercise training on atrial fibrillation: a META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS","volume":"42","author":"Oesterle","year":"2022","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2024122405404917200_euae298-B29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacep.2022.12.002","article-title":"An exercise and physical activity program in patients with atrial fibrillation: the ACTIVE-AF randomized controlled trial","volume":"9","author":"Elliott","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2024122405404917200_euae298-B30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ahj.2014.12.024","article-title":"Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"169","author":"Holmqvist","year":"2015","journal-title":"Am Heart J"},{"key":"2024122405404917200_euae298-B32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2013.03.052","article-title":"Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation","volume":"62","author":"Fein","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/europace\/euu066","article-title":"Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies","volume":"16","author":"Li","year":"2014","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hrthm.2012.11.015","article-title":"Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy","volume":"10","author":"Naruse","year":"2013","journal-title":"Heart rhythm Heart Rhythm"},{"key":"2024122405404917200_euae298-B35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2021.1489","article-title":"Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial","volume":"325","author":"Albert","year":"2021","journal-title":"JAMA"},{"key":"2024122405404917200_euae298-B36","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.amjcard.2015.08.046","article-title":"Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea","volume":"116","author":"Qureshi","year":"2015","journal-title":"Am J Cardiol"},{"key":"2024122405404917200_euae298-B37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jacep.2015.02.014","article-title":"Effect of obstructive sleep apnea treatment on atrial fibrillation recurrence: a meta-analysis","volume":"1","author":"Shukla","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2024122405404917200_euae298-B38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jacep.2022.04.015","article-title":"Impact of CPAP on the atrial fibrillation substrate in obstructive sleep apnea: the SLEEP-AF study","volume":"8","author":"Nalliah","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2024122405404917200_euae298-B39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"Friberg","year":"2010","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B40","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.ijcard.2012.06.118","article-title":"Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project","volume":"167","author":"Banerjee","year":"2013","journal-title":"Int J Cardiol"},{"key":"2024122405404917200_euae298-B41","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"2024122405404917200_euae298-B42","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2024122405404917200_euae298-B43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2024122405404917200_euae298-B44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/europace\/eut333","article-title":"Atrial fibrillation patients do not benefit from acetylsalicylic acid","volume":"16","author":"Sj\u00e4lander","year":"2014","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B46","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/clc.23257","article-title":"Risk of ischemic stroke and utility of CHA2 DS2-VASc score in women and men with atrial fibrillation","volume":"42","author":"Tomasdottir","year":"2019","journal-title":"Clin Cardiol"},{"key":"2024122405404917200_euae298-B47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2019-315065","article-title":"Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation","volume":"106","author":"Wu","year":"2020","journal-title":"Heart"},{"key":"2024122405404917200_euae298-B48","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1538-7836.2012.04853.x","article-title":"Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study","volume":"10","author":"Mikkelsen","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2024122405404917200_euae298-B49","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1093\/eurheartj\/ehae539","article-title":"Gender and contemporary risk of adverse events in atrial fibrillation","volume":"45","author":"Champsi","year":"2024","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B50","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehu367","article-title":"Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation","volume":"35","author":"Cappato","year":"2014","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B51","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0140-6736(16)31474-X","article-title":"Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial","volume":"388","author":"Goette","year":"2016","journal-title":"Lancet"},{"key":"2024122405404917200_euae298-B52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11239-018-1622-5","article-title":"Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis","volume":"45","author":"Brunetti","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"2024122405404917200_euae298-B53","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/01.CIR.0000118472.77237.FA","article-title":"Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Steinberg","year":"2004","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B54","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.3390\/jcm10173979","article-title":"Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: a systematic review and meta-analysis of 81,462 patients","volume":"10","author":"Sgreccia","year":"2021","journal-title":"J Clin Med"},{"key":"2024122405404917200_euae298-B55","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/europace\/euz312","article-title":"Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality","volume":"22","author":"Camen","year":"2020","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B56","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2017.10.085","article-title":"Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation","volume":"71","author":"Chao","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12471-019-1272-z","article-title":"Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study","volume":"27","author":"Weijs","year":"2019","journal-title":"Neth Heart J"},{"key":"2024122405404917200_euae298-B59","doi-asserted-by":"crossref","first-page":"e13489","DOI":"10.1111\/eci.13489","article-title":"Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: a ten-year follow-up","volume":"51","author":"Bezabhe","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"2024122405404917200_euae298-B60","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3390\/jcm9041234","article-title":"Incident comorbidities, aging and the risk of stroke in 608,108 patients with atrial fibrillation: a nationwide analysis","volume":"9","author":"Fauchier","year":"2020","journal-title":"J Clin Med"},{"key":"2024122405404917200_euae298-B61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.25700","article-title":"Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"87","author":"Seiffge","year":"2020","journal-title":"Ann Neurol"},{"key":"2024122405404917200_euae298-B62","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/STROKEAHA.115.009487","article-title":"Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS trial","volume":"46","author":"Senoo","year":"2015","journal-title":"Stroke"},{"key":"2024122405404917200_euae298-B63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann Neurol"},{"key":"2024122405404917200_euae298-B64","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp-2021-328391","article-title":"Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"93","author":"Polymeris","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024122405404917200_euae298-B65","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1161\/STROKEAHA.121.038239","article-title":"Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral anticoagulants: the RENO-EXTEND study","volume":"53","author":"Paciaroni","year":"2022","journal-title":"Stroke"},{"key":"2024122405404917200_euae298-B66","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.jacc.2017.03.600","article-title":"Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction","volume":"69","author":"Yao","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B67","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.jacc.2016.09.966","article-title":"Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry","volume":"68","author":"Steinberg","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B68","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/jamacardio.2016.1829","article-title":"Apixaban 5mg twice daily and clinical outcomes in patients with atrial fibrillation and advanced age, low body weight, or high creatinine: a secondary analysis of a randomized clinical trial","volume":"1","author":"Alexander","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2024122405404917200_euae298-B69","doi-asserted-by":"crossref","first-page":"euad302","DOI":"10.1093\/europace\/euad302","article-title":"Characteristics of patients with atrial fibrillation treated with direct oral anticoagulants and new insights into inappropriate dosing: results from the French National Prospective Registry: PAFF","volume":"25","author":"Guenoun","year":"2023","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B70","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B71","doi-asserted-by":"crossref","first-page":"euad237","DOI":"10.1093\/europace\/euad237","article-title":"Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders","volume":"25","author":"Lakkireddy","year":"2023","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B72","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1093\/europace\/eux211","article-title":"Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery","volume":"20","author":"Caliskan","year":"2018","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B73","first-page":"100998","article-title":"Outcomes of cardiac surgery with left atrial appendage occlusion versus no occlusion, direct oral anticoagulants, and vitamin K antagonists: a systematic review with meta-analysis","volume":"40","author":"Nso","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2024122405404917200_euae298-B74","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2019.07.032","article-title":"Meta-analysis evaluating outcomes of surgical left atrial appendage occlusion during cardiac surgery","volume":"124","author":"Ibrahim","year":"2019","journal-title":"Am J Cardiol"},{"key":"2024122405404917200_euae298-B75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13019-018-0740-7","article-title":"Adding left atrial appendage closure to open heart surgery provides protection from ischemic brain injury six years after surgery independently of atrial fibrillation history: the LAACS randomized study","volume":"13","author":"Park-Hansen","year":"2018","journal-title":"J Cardiothorac Surg"},{"key":"2024122405404917200_euae298-B76","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/jocs.15335","article-title":"Improved outcomes in CABG patients with atrial fibrillation associated with surgical left atrial appendage exclusion","volume":"36","author":"Soltesz","year":"2021","journal-title":"J Card Surg"},{"key":"2024122405404917200_euae298-B77","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jacep.2018.03.009","article-title":"Thoracoscopic left atrial appendage clipping: a multicenter cohort analysis","volume":"4","author":"van Laar","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2024122405404917200_euae298-B78","doi-asserted-by":"crossref","first-page":"euae188","DOI":"10.1093\/europace\/euae188","article-title":"Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial","volume":"26","author":"Aarnink","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B79","doi-asserted-by":"crossref","first-page":"euad244","DOI":"10.1093\/europace\/euad244","article-title":"Progress in atrial fibrillation ablation during 25 years of Europace journal","volume":"25","author":"Boersma","year":"2023","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"2024122405404917200_euae298-B81","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"Ja\u00efs","year":"2008","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B82","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.jacc.2020.04.065","article-title":"Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial","volume":"75","author":"Poole","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B83","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B84","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B86","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B87","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B88","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"2024122405404917200_euae298-B89","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"2024122405404917200_euae298-B90","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/europace\/euab185","article-title":"Catheter ablation vs. antiarrhythmic drugs as \u2018first-line\u2019 initial therapy for atrial fibrillation: a pooled analysis of randomized data","volume":"23","author":"Chen","year":"2021","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B91","doi-asserted-by":"crossref","first-page":"euae104","DOI":"10.1093\/europace\/euae104","article-title":"Comprehensive atrial fibrillation burden and symptom reduction post-ablation: insights from DECAAF II","volume":"26","author":"Noujaim","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B92","doi-asserted-by":"crossref","first-page":"euad335","DOI":"10.1093\/europace\/euad335","article-title":"Durability of pulmonary vein isolation for atrial fibrillation: a meta-analysis and systematic review","volume":"25","author":"Serban","year":"2023","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B93","doi-asserted-by":"crossref","first-page":"euad185","DOI":"10.1093\/europace\/euad185","article-title":"EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry","volume":"25","author":"Schmidt","year":"2023","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B94","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/clc.22904","article-title":"Recurrence rate of atrial fibrillation after the first clinical episode: a prospective evaluation using continuous cardiac rhythm monitoring","volume":"41","author":"Simantirakis","year":"2018","journal-title":"Clin Cardiol"},{"key":"2024122405404917200_euae298-B95","doi-asserted-by":"crossref","first-page":"euae070","DOI":"10.1093\/europace\/euae070","article-title":"Longer and better lives for patients with atrial fibrillation: the 9th AFNET\/EHRA consensus conference","volume":"26","author":"Linz","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B96","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/euac062","article-title":"Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET\/EHRA consensus conference","volume":"25","author":"Schnabel","year":"2023","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B97","doi-asserted-by":"crossref","first-page":"euae121","DOI":"10.1093\/europace\/euae121","article-title":"Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial","volume":"26","author":"Rillig","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B98","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024122405404917200_euae298-B100","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jacep.2020.08.019","article-title":"Catheter ablation versus medication in atrial fibrillation and systolic dysfunction: late outcomes of CAMERA-MRI study","volume":"6","author":"Sugumar","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2024122405404917200_euae298-B101","doi-asserted-by":"crossref","first-page":"euae043","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B102","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1093\/eurheartj\/ehz443","article-title":"Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B103","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B104","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B105","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC Multicenter Randomized Trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B106","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/europace\/euac173","article-title":"Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials","volume":"25","author":"Simader","year":"2023","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B107","doi-asserted-by":"crossref","first-page":"e007731","DOI":"10.1161\/CIRCEP.119.007731","article-title":"Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA Trial","volume":"12","author":"Kuck","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024122405404917200_euae298-B108","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","article-title":"Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial","volume":"145","author":"Parkash","year":"2022","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B109","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B110","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehy148","article-title":"Apixaban compared to heparin\/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial","volume":"39","author":"Ezekowitz","year":"2018","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B111","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jama.2014.3824","article-title":"Time to cardioversion for acute atrial fibrillation and thromboembolic complications","volume":"312","author":"Nuotio","year":"2014","journal-title":"JAMA"},{"key":"2024122405404917200_euae298-B112","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/europace\/euu189","article-title":"Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy","volume":"17","author":"Hansen","year":"2015","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B113","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15441\/ceem.17.286","article-title":"Effectiveness and safety of electrical cardioversion for acute-onset atrial fibrillation in the emergency department: a real-world 10-year single center experience","volume":"6","author":"Bonfanti","year":"2019","journal-title":"Clin Exp Emerg Med"},{"key":"2024122405404917200_euae298-B114","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1161\/CIRCULATIONAHA.111.069450","article-title":"Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities","volume":"125","author":"Rienstra","year":"2012","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijcard.2015.03.122","article-title":"\u201cAsymptomatic\u201d persistent or permanent atrial fibrillation: a misnomer in selected patients","volume":"185","author":"Ganapathy","year":"2015","journal-title":"Int J Cardiol"},{"key":"2024122405404917200_euae298-B116","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1900353","article-title":"Early or delayed cardioversion in recent-onset atrial fibrillation","volume":"380","author":"Pluymaekers","year":"2019","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B117","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.114.014058","article-title":"Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study","volume":"131","author":"Lubitz","year":"2015","journal-title":"Circulation"},{"key":"2024122405404917200_euae298-B118","doi-asserted-by":"crossref","first-page":"e007716","DOI":"10.1161\/CIRCEP.119.007716","article-title":"Initial precipitants and recurrence of atrial fibrillation","volume":"13","author":"Wang","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024122405404917200_euae298-B119","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/jpm12040547","article-title":"Prevalence of new-onset atrial fibrillation and associated outcomes in patients with sepsis: a systematic review and meta-analysis","volume":"12","author":"Corica","year":"2022","journal-title":"J Pers Med"},{"key":"2024122405404917200_euae298-B120","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ehjacc\/zuac080","article-title":"New-onset atrial fibrillation in intensive care: epidemiology and outcomes","volume":"11","author":"Bedford","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2024122405404917200_euae298-B121","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jacc.2018.07.088","article-title":"Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery","volume":"72","author":"Butt","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B122","doi-asserted-by":"crossref","first-page":"e028468","DOI":"10.1136\/bmjopen-2018-028468","article-title":"Comparative thromboembolic risk in atrial fibrillation with and without a secondary precipitant-Danish nationwide cohort study","volume":"9","author":"Gundlund","year":"2019","journal-title":"BMJ Open"},{"key":"2024122405404917200_euae298-B123","doi-asserted-by":"crossref","first-page":"e021746","DOI":"10.1161\/JAHA.121.021746","article-title":"Secondary precipitants of atrial fibrillation and anticoagulation therapy","volume":"10","author":"Ko","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2024122405404917200_euae298-B124","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacep.2017.08.003","article-title":"Anticoagulant use and risk of ischemic stroke and bleeding in patients with secondary atrial fibrillation associated with acute coronary syndromes, acute pulmonary disease, or sepsis","volume":"4","author":"Quon","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2024122405404917200_euae298-B125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B126","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"2024122405404917200_euae298-B127","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/eurheartj\/ehae365","article-title":"Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation","volume":"45","author":"Sanders","year":"2024","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B128","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024122405404917200_euae298-B129","doi-asserted-by":"crossref","first-page":"e2014874","DOI":"10.1001\/jamanetworkopen.2020.14874","article-title":"Trends in atrial fibrillation incidence rates within an integrated health care delivery system, 2006 to 2018","volume":"3","author":"Williams","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024122405404917200_euae298-B130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1258\/0969141053279086","article-title":"Current concepts in screening for noncommunicable disease: World Health Organization Consultation Group Report on methodology of noncommunicable disease screening","volume":"12","author":"Strong","year":"2005","journal-title":"J Med Screen"},{"key":"2024122405404917200_euae298-B131","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00392-022-02117-9","article-title":"Screening strategies for atrial fibrillation in the elderly population: a systematic review and network meta-analysis","volume":"112","author":"Whitfield","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"2024122405404917200_euae298-B132","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"2024122405404917200_euae298-B133","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2022.07.015","article-title":"Screening for atrial fibrillation in the elderly: a network meta-analysis of randomized trials","volume":"105","author":"Elbadawi","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2024122405404917200_euae298-B134","doi-asserted-by":"crossref","first-page":"oeac044","DOI":"10.1093\/ehjopen\/oeac044","article-title":"Screening for atrial fibrillation to prevent stroke: a meta-analysis","volume":"2","author":"McIntyre","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2024122405404917200_euae298-B135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/eurheartj\/ehac547","article-title":"Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study","volume":"44","author":"Lyth","year":"2023","journal-title":"Eur Heart J"},{"key":"2024122405404917200_euae298-B136","doi-asserted-by":"crossref","first-page":"euae234","DOI":"10.1093\/europace\/euae234","article-title":"Increasing the reach: optimizing screening for atrial fibrillation-the STROKESTOP III study","volume":"26","author":"Khan","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B137","doi-asserted-by":"crossref","first-page":"euae178","DOI":"10.1093\/europace\/euae178","article-title":"Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association","volume":"26","author":"Sterli\u0144ski","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B138","doi-asserted-by":"crossref","first-page":"euae012","DOI":"10.1093\/europace\/euae012","article-title":"Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physician survey-how are we dealing with controversial approaches?","volume":"26","author":"Guerra","year":"2024","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B139","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/europace\/eux299","article-title":"European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace"},{"key":"2024122405404917200_euae298-B140","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/europace\/euac052","article-title":"Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: proceedings of the European Society of Cardiology Cardiovascular Round Table","volume":"24","author":"Leclercq","year":"2022","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/12\/euae298\/61268750\/euae298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/12\/euae298\/61268750\/euae298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:42:39Z","timestamp":1735000959000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euae298\/7931832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":140,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euae298","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,12]]},"article-number":"euae298"}}